Dr. Adi Mor
Equibles does not estimate personal net worth.
Get an email with a short summary when Chemomab Therapeutics Ltd. publishes a filing, an earnings call transcript or a press release.
Get CMMB alertsAbout Dr. Adi Mor
Dr. Adi Mor is recorded as CEO at Chemomab Therapeutics Ltd. (CMMB) since June 1, 2023. Chemomab Therapeutics Ltd. reported in an 8-K filed June 5, 2023 that Dr. Adi Mor was appointed Chief Executive Officer, effective June 1, 2023. Chemomab Therapeutics Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Chemomab Therapeutics Ltd. includes Adi Mor (CEO and Board Member), Dale Pfost (CEO and Board Member), Dr. Dale Pfost (CEO) and 7 others.
“On June 1, 2023, the board of directors (the “Board”) of Chemomab Therapeutics Ltd. (the “Company” or “Chemomab”) appointed Dr. Adi Mor, co-founder of the Company, a current class III member of the Board and the Company’s Chief Scientific Officer, as Chief Executive Officer of the Company to replace Dr. Dale Pfost, effective as of the same date.”
Affiliation history
-
Current
2023-06-01–present
Company network
Leadership on record at Chemomab Therapeutics Ltd.
- Adi Mor CEO, Board Member
- Dale Pfost CEO, Board Member
- Dr. Dale Pfost CEO
- Neil Cohen CEO, Board Member
- Dr. Nissim Darvish Chairman
- Stephen Squinto Chairman, Board Member
- Andrew Fine CFO
- Donald Marvin CFO, COO
- Ms. Sigal Fattal CFO
- Sigal Fattal CFO